Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhixiangpi + baizhi is a combination of two traditional Chinese medicinal (TCM) botanical extracts: the peel of Citrus aurantium (Zhixiangpi) and the root of Angelica dahurica (Baizhi). This combination is primarily utilized in the treatment of vitiligo, typically formulated as a topical tincture. The therapeutic mechanism is driven by the presence of linear furanocoumarins (psoralens), such as xanthotoxin (8-methoxypsoralen) and bergapten (5-methoxypsoralen), which are found in both herbs. These compounds act as photosensitizers that intercalate into the DNA of melanocytes; upon exposure to ultraviolet A (UVA) light, they form covalent adducts with pyrimidine bases, stimulating melanocyte proliferation and increasing tyrosinase activity. This process facilitates melanogenesis and the subsequent repigmentation of depigmented skin patches, effectively functioning as a natural form of psoralen plus ultraviolet A (PUVA) therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zhixiangpi + baizhi.